Regenecare® Wound Care Gel
**Please email a copy of your prescription to info@mpmmed.com**
An amorphous hydrogel dressing proven to help reduce pain intensity without side effects Proven to help reduce both pain and itching in cross-over study
Regenecare Wound Gels have been shown to be effective in the local management of:
Dermatological Problems
Why they work:
Directions:
THIS IS AN Rx ITEM. UPON PLACING YOUR ORDER ONLINE, FAX A COPY OF YOUR PRESCRIPTION TO 972-893-4092. WE MUST RECEIVE THIS DOCUMENTATION TO PROCESS YOUR ORDER.
Case Studies - Regenecare® Wound Care Gel
- A pilot crossover study to evaluate the use of Regenecare topical wound gel in patients with cutaneous toxicity caused by epidermal growth factor receptor (HER1/EGFR) inhibitors.Citation: Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 19643 Author(s): S. Wong, K. E. Osann, K. P. Lloyd, C. M. Vasko, R. L. Arcinas, M. Mummaneni Download
- A Pilot Cross-Over study to evaluate the use of Regenecare® topical gel in patients with cutaneous toxicity caused by epidermal growth factor receptor (HER1/EGFR) inhibitors. SF Wong, Pharm D. K Lloyd MS, C Vasko RN, OCN, NP, M Mummaneni M.D., K Osann PhD. Presented at 9th National Conference on Cancer Nursing Research, 2007, 126, Oncology Nursing Forum, Download
- Evaluation of Regenecare® Topical Gel in the Treatment of Skin Rash Associated with Cetuximab (Erbitux®), Tarceva® and Other EGFR Inhibitors-Treated Cancer Patients. M. Kozloff, M.D., PA Gowland, RN, BSN, OCN, CCRC, J Vlamakis RN, OCN, J Koch RN BSN, G Ratko RN, BSN, L Gravitt RN, OCN, D Palmer CCRP, Ingalls Memorial Hospital, Cancer Research Center. Harvey Ill., 2007. Download
- Evaluation of Cutaneous Skin Rash in Subjects Treated with Regenecare® Topical Gel (Collagen, Aloe vera, & 2% Lidocaine) During Erbitux® and Combination Therapies for Cancer. SF Wong, Pharm D, Western University of Health Sciences, College of Pharmacy, Pamona CA, Faculty in Residence Hematology Oncology Medical Group of Orange County, CA, Nov. 2006. Download
- Case Studies Evaluating Regenecare® Topical Gel, with 2% Lidocaine HCl, Collagen & Aloe Vera for Treating Cutaneous Rash Associated with EGFR (HER!/EGFR) Inhibitors. S F Wong, Pharm D, Western University of Health Sciences, College of Pharmacy, Pamona CA, Faculty in Residence Hematology Oncology Medical Group of Orange County, Orange CA, Nov. 2006. Download
- Regenecare® with Lidocaine Has Been Used Successfully on Over 400 Patients by Southwest Regional Wound Care Center, Lubbock, Texas to Anesthetize Wounds Prior to Debridement. Randall Wolcott M.D., P.A., American Professional Wound Care Association, 2006. Download
- Evaluation of Tropical Gel(With 2% Lidocaine-HCI) for Treatment of Adverse Rash Sympotoms Associated With EGFR/HER1 Inhibitors M.F.Kozloff, P.A. Gowland, J.Vlamakis, J.Koch, K.P.Lloyd, J.B.Spalding Ingalls Memorial Hospital, Cancer Research Center, Harvey, Illinois; MPM Medical Inc., Irving, Texas; University of North Texas, Denton, Texas Download
- A Cross-Over Clinical Study of Forty Seven Patients with Painful Deep Wounds Showed Regenecare® Hydrogel Application was Highly Significant in Alleviating Dressing Related Pain. Download
- Ten Patients with Painful Deep Wounds Evaluate Pain with Application of 2% Lidocaine Jelly Versus Regenecare® Wound Gel with 2% Lidocaine During Dressing Change Download
